Newsroom press releases

09/11/17 - 14:15

GROWTH IN REVENUES AND NET PROFIT IN Q3 2017. STRONG FREE CASH FLOW GENERATION. 2017 GUIDANCE CONFIRMED (1001.87 KB)

Financial Data

29/09/17 - 15:00

DiaSorin revises its guidance upwards for 2019 as a consequence of the completion of the acquisition of ELISA immunodiagnostic business portfolio and associated assets from SIEMENS (928.39 KB)

Financial Data

29/09/17 - 14:15

DiaSorin completes the acquisition of the ELISA immunodiagnostic business portfolio and associated assets from SIEMENS HEALTHINEERS (332.93 KB)

Acquisition / Partnership

03/08/17 - 14:45

DiaSorin Group reports strong growth in revenues and profitability in Q2 2017 (1015.93 KB)

Financial Data

25/07/17 - 21:00

DiaSorin to acquire ELISA immunodiagnostic business portfolio and associated assets from SIEMENS HEALTHINEERS (443.45 KB)

Acquisition / Partnership

26/06/17 - 9:45

DiaSorin presents its 2017-2019 Industrial Plan (479.98 KB)

Financial Data

23/06/17 - 9:30

DiaSorin and TECAN to collaborate in new platform development (755.46 KB)

Acquisition / Partnership

22/06/17 - 19:45

DiaSorin and QIAGEN sign collaboration to expand Liaison test menu through adoption of select QIAGEN assays (430.67 KB)

Acquisition / Partnership

08/05/17 - 19:30

DiaSorin Group reports growth in revenues and profitability in the first quarter 2017, generating a relevant cash flow (984.86 KB)

Financial Data

27/04/17 - 18:45

DiaSorin - Annual General Meeting 2016 (421.04 KB)

Financial Data

08/03/17 - 15:30

The Board of Directors approves the results for FY'16 (1.13 MB)

Financial Data